FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2115022311> ?p ?o ?g. }

• W2115022311 endingPage "55" @default.
• W2115022311 startingPage "31" @default.
• W2115022311 abstract "Immunological ReviewsVolume 129, Issue 1 p. 31-55 Use of Monoclonal Antibodies in vivo as a Therapeutic Strategy for Alloimmune or Autoimmune Reactivity: The Besançon Experience P. Herve, Corresponding Author P. Herve Centre Regional de Transfusion Sanguine, 'Patrick Herve, MD, Centre Regional de Transfusion Sanguine, 1, Boulevard Fleming, 25020 Besançon, France.Search for more papers by this authorE. Racadot, E. Racadot Centre Regional de Transfusion Sanguine, 'Search for more papers by this authorD. Wendling, D. Wendling Service de Rhumatologie, Hopital Jean Minjoz Centre Regional de Transfusion Sanguine, 'Search for more papers by this authorL. Rumbach, L. Rumbach Service de Neurologic Hopital Jean Minjoz, Besançon, France. Centre Regional de Transfusion Sanguine, 'Search for more papers by this authorP. Tiberghien, P. Tiberghien Bone Marrow Transplantation Unit, Hopital Jean Minjoz Centre Regional de Transfusion Sanguine, 'Search for more papers by this authorJ. Y. Cahn, J. Y. Cahn Bone Marrow Transplantation Unit, Hopital Jean Minjoz Centre Regional de Transfusion Sanguine, 'Search for more papers by this authorM. Flesch, M. Flesch Bone Marrow Transplantation Unit, Hopital Jean Minjoz Centre Regional de Transfusion Sanguine, 'Search for more papers by this authorJ. Wijdenes, J. Wijdenes Centre Regional de Transfusion Sanguine, 'Search for more papers by this author P. Herve, Corresponding Author P. Herve Centre Regional de Transfusion Sanguine, 'Patrick Herve, MD, Centre Regional de Transfusion Sanguine, 1, Boulevard Fleming, 25020 Besançon, France.Search for more papers by this authorE. Racadot, E. Racadot Centre Regional de Transfusion Sanguine, 'Search for more papers by this authorD. Wendling, D. Wendling Service de Rhumatologie, Hopital Jean Minjoz Centre Regional de Transfusion Sanguine, 'Search for more papers by this authorL. Rumbach, L. Rumbach Service de Neurologic Hopital Jean Minjoz, Besançon, France. Centre Regional de Transfusion Sanguine, 'Search for more papers by this authorP. Tiberghien, P. Tiberghien Bone Marrow Transplantation Unit, Hopital Jean Minjoz Centre Regional de Transfusion Sanguine, 'Search for more papers by this authorJ. Y. Cahn, J. Y. Cahn Bone Marrow Transplantation Unit, Hopital Jean Minjoz Centre Regional de Transfusion Sanguine, 'Search for more papers by this authorM. Flesch, M. Flesch Bone Marrow Transplantation Unit, Hopital Jean Minjoz Centre Regional de Transfusion Sanguine, 'Search for more papers by this authorJ. Wijdenes, J. Wijdenes Centre Regional de Transfusion Sanguine, 'Search for more papers by this author First published: October 1992 https://doi.org/10.1111/j.1600-065X.1992.tb01418.xCitations: 19AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Anderson, J. P., Blue, M. L. & Schlossman, S. F. (1988) Comodulation of CD3 and CD4. Evidence for a specific association between CD4 and approximately 5% of the CD3: T-cell receptor complexes on helper T lymphocytes. J Immunol. 140, 1732. Arend, W. P. & Dayer, J. M. (1990) Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 33, 305. Arnett, F C. Deworthy, S. M. & Bloch, D. A. (1988) The American rheumatism association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum. 31, 315. Carteron, N. U Schimenti, C. L. & Wofsy, D. (1989) Treatment of murine lupus with F(ab′)2 fragments of monoclonal antibody to L3T4, J. Immunol. 142, 1470. Chofflon, M., Weiner, H. L., Morimoto, C. & Hafler, D. A. (1988) Loss of functional suppression is linked to decreases in circulating supprossor inducer (CD4+ 2H4+) T cells in multiple sclerosis, Ann. Neurol. 24, 185. Cole, J. A., McCarthy, S. A., Rees, M. A., Sharrow, S. O. & Singer, A. (1989) Cell surface comodulation of CD4 and T-cell receptor by anti-CD4 monoclonal antibody. J. Immunol. 143, 397. Dasgupta, B., Corkill, M., Kirkham, B., Gibson, T. & Panayi, G. (1992) Serial estimation of interleukin 6 as measure of systemic disease in rheumatoid arthritis. J Rheumatol. 19, 22. Deber, C. M. & Reynolds, S. J. (1991) Central nervous system myelin: structure, function and pathology. Clin. Biochem. 42, 113. Duke, O., Panayi, G. S., Janossy, G. & Poulter, L. W. (1982) An immuno-histological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. Clin. Exp. Immunol. 49, 22. Feldmann, M., Brennan, F. M. & Chantry, D., (1990) Cytokine production in the rheumatoid joint: implications for treatment. Ann. Rheum. Dis. 49, 480. Ferrara, J. & Deeg, H. J. (1991) Graft-versus-host disease. New Engl, J. Med. 324, 667. Ferrara, J., Marion, A., McIntyre, J. F. Murphy, G. F. & Burakoff, S. J. (1986) Amelioration of acute GvHD due to minor histocompatibility antigens by in vivo administration of anti-IL-2 receptor antibody. J. Immunol. 137, 1874. Fressinaud, C. Sarlieve, L. L. & Vincendon, G. (1990) Sclérose en plaques: revue des principals donneés experimentales et des hypotheses pathogéniques. Rev. Med. Int. 91, 9. Gauldie, J., Northemann, W & Fey, G. H., (1990) IL6 functions as an exocrine hormone in inflammation, J Immunol. 144, 3804. Guerne, P. A., Zuraw, B. L., Vaughan, J. H., Carson, D. A. & Lotz, M., (1989) Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin. Invest. 83, 585. Gutstein, N. I. & Wofsy, D. (1986) Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4 cells. J. Immunol. 137, 3414. Hafler, D. A., Ritz, J., Schlossman, S. F & Weiner, H. L. (1988) Anti-CD4 and anti-CD2 monoclonal antibody infusions In subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses. J. Immunol. 141, 131. Hafler, D. A. & Weiner, H. L. (1988) Immunosuppression with monoclonal antibodies in multiple sclerosis. Neurol. 38, 42. Harris, E. D., (1990) Rheumatoid arthritis: pathophysiology and implications for therapy. New Engl, J. Med. 322, 1277. Hauser, S. L., Dawson, D. M., Lehrich, J. R., Beal, M. F., Levy, S. V., Popper, R. O., Nills, J. A. & Weiner, H. L. (1983) Intensive Immuno-suppression in progressive multiple sclerosis. New Engl, J. Med. 308, 173. Heinrich, P. C. Castell, J. V. & Andus, T. (1990) Interleukin 6 and the acute phase response. Biochem, J. 265, 621. Henslee-Downey, R J. (1990) Treatment of acute graft-versus-host disease. In: Graft-Versus-Host Disease. Eds. S. J. Burakoff, H. J. Deeg, J. Ferrara & K. Atkinson Marcel Dekker, Inc. New York and Basel : 487. Herve, P. (1991b) Perspectives in the prevention and treatment of acute graft-versus-host disease. Bone Marrow Transplant. 7, 117 (suppl 2). Herve, P., Bordigoni, P., Cahn, J. Y., Flesch, M., Tiberghien, R., Racadot E., Milpied, N., Bergerat, J. P., Plouvier, E., Roche, C. & Wijdenes, J. (1991a) Use of monoclonal antibodies in vivo as a therapeutic strategy for acute GvHD in matched and mismatched bone marrow transplantation. Transplant. Proc. 23, 1692. Herve, P., Cahn, J. Y. & Beatty, P. G. (1990a) Graft-versus-host disease after bone marrow transplantation from donors other than HLA-identical siblings. In: Graft-Versus-Host Disease. Eds. S. J. Burakoff, H. J. Deeg, J. Ferrara & K. Atkinson Marcel Dekker Inc, New York and Basel : 425. Herve, R. Flesch, M., Tiberghien, P., Wijdenes, J., Racadot, E., Bordigoni, P., Plouvier, E., Stephan, J. L., Bourdeau, H., Holler, F. Lioure, B., Roche, C. Wilmer, E., Demeocq, F. Kuentz, M. & Cahn, J. Y. (1992) Phase I-H trial of a monoclonal anti TNFα antibody for the treatment of refractory severe acute graft-versus-host disease. Blood 79, 3362. Herve, P., Wijdenes, J., Bergerat, J. P., Bordigoni, P., Milpied, N., Cahn, J. Y., Clement, C. Beliard, R., Morel-Fourder, B., Racadot, E., Troussard, X., Benz-Lemoine, F. Gaud, C. Legros, M., Attal, M., Kloft, M. & Peters, A. (1990b) Treatment of cortico-steroid-resistant acute graft-versus-host disease by in vivo administration of anti-Inter-leukin-2 receptor monoclonal antibody (B-BIO). Blood 75, 1017. Herzog, C. (1990) Monoclonal CD4 antibodies after accidental HIV infection. Lancet 336, 1007. Herzog, C. Walker, C. Pichler, W. J., Aeschlimann, A., Wassmer, P., Stockinger, H., Knapp, W., Rieber, P. & Muller, W. (1987) Monoclonal anti-CD4 in arthdtis. Lancet 1, 1461. Hirano, T. Matsuda, T. Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimizu, M., Maini, R., Feldmann, M. & Kishimoto, T. (1988) Excessive production of IL6 in rheumatoid arthritis. Eur J. Immunol. 18, 1797. Holler, E., Kolb, H. J., Moller, A., Kempeni, J., Lie Senfeld, S., Pechumer, H., Lehmacher, W. Ruckdeschel, G., Gleinex, B., Riedner, C. Ledderose, G., Brehm, G., Mittermuller, J. & Willmanns, W. (1990) Increased serum levels of tumor necrosis factor alpha precede major complication of bone marrow transplantation. Blood 75, 1011. Homeff, G., Burmester, G. R., Emmrich, F. & Kalden, J. R. (1991) Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum. 34, 129. Israelski, D. M., Araujo, F. G., Conley, F. K., Suzuki, Y., Sharma, S. & Remington, J. S. (1989) Treatment with anti-L3T4 (CD4) monoclonal antibody reduces the inflammatory response in toxoplasmic encephalitis, J. Immunol. 142, 954. Klein, B., Wijdenes, J., Zhang, X. G., Jourdan, M., Boiron, J. M., Brochier, J., Liautard, J., Merlin, M., Clement, C. Morel-Fourrier, B., Lu, Z. Y. Mannoni, P., Sany, J. & Bataille, R. (1991) Murine anti-intedeukin 6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 78, 1198. Korngold, R. & Sprent, J. (1987) T-cell subsets and graft-versus-host disease. Transplantation 44, 335. Kurtzke, J. F. (1983) Rating neurologic impairment In multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444. Larsson, R. Holmdahl, R., Dencker, L. & Klareskog, L. (1985) In vivo treatment with W3/ 13 (anti pan T) but not with 0X8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats. Immunology 56, 383. Lasky, H. P., Bauer, K. & Pope, R. M. (1988) Increased helper inducer and decreased suppressor inducer phenotypes in the rheumatoid joint. Arthritis Rheum. 31, 52. Lavelle-Jones, M., Al-Hadrani, A., Spiers, E. M., Campbell, F C. & Cuschieri, A. (1990) Reactivation of rheumatoid arthritis during continuous infusion of interleukin 2: evidence of lymphocytic control of rheumatoid disease. Br. Med. J. 301, 97. Lipsky, P. E. (1989) The control of antibody production by immunomodulatory molecules. Arthritis Rheum. 32, 1345. Martin, P J., Schoch, G., Fischer, L., Byers, V. Appelbaum, F R., McDonald, G. B., Storb, R. & Hansen, J. A. (1991) A restrospective analysis of therapy for acute graft- versus-host disease: secondary treatment. Blood 77, 1821. Mazerolles, F. Auffray, C. & Fischer, A. (1991) Down regulation of T-cell adhesion by CD4. Human Immunology 31, 40. McFarland, H. R & Dhib-Jalbut, S. (1989) Multiple sclerosis: possible immunological mechanisms, Clin. Immunol. Immunopathol. 50, 96. Moller, J. R., Johnson, D., Brady, R. O., Tourtelotte, W. W. & Quarles, R. H. (1989) Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol. 22, 55. Noronha, A., Richman, D. P. & Arnason, B. G. W. (1985) Multiple sclerosis: activated cells in cerebrospinal fluid in acute exacerbations. Ann. Neurol. 18, 722. Piquet, P. F. (1990) Tumor necrosis factor and graft-versus-host disease: In: Graft-Versus- Host Disease. Eds. S. J. Burakoff, H. J. Deeg, J. Ferrara & K. Atkinson Marcel Dekker Inc. New York and Basel : 255. Piguet, P. F., Grau, G. E., Allet, B. & Vasalli, P. (1987) Tumor necrosis factor/cachectin is an effector of skin and gut lesions in the acute phase of graft-versus-host disease. J. Exp. Med 166, 1280. Pinals, R. S., Masi, A. T. & Larsen, R. A., (1981) Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum. 24, 1308. Pitzalis, C. Kingsley, G., Murphy, J. & Panayi, G. (1987) Abnormal distrubution of the helper-inducer and suppressor induced T lymphocyte subsets in the rheumatoid joint. Clin. Immunol. Immunopathol. 45, 252. Poser, C. M., Paty, D. W. Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C. Johnson, K. P., Sibley, W. A., Silberberg, D. H. & Tourtelotte, W. W. (1983) New diagnosis criteria for multiple sclerosis: guidelines for research protocols, Ann. Neurol 1, 227. Racadot, E., Wijdenes, J. & Wendling, D. (1992) Immunological follow up of 17 patients with rheumatoid arthritis treated in vivo with an anti-T CD4 monoclonal antibody (B-F5). Clin. Exp. Rhumatol. (in press). Raine, C. S. (1990) Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination. In: Immunologic Mechanisms in Neurologic and Psychiatric Disease. Ed. B. H. Waksman Raven Press, Ltd., New York : 37. Ranges, G. E., Sriram, S. & Cooper, S. M. (1985) Prevention of type II collagen induced arthritis by in vivo treatment with anti L3T4. J Exp. Med 162, 1105. Reiter, C. Kakavand, B., Rieber, E. P. Schattenkirchner, M., Riethmuller, G. & Kruger, K. (1991) Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Arthritis Rheum. 34, 525. Sany, J. (1990) Immunological treatment of rheumatoid arthritis. Clin. Exp. Rheumatol. 8, 81 (suppl 5). Schizuru, J. A., Taylor-Edwards, C. Banks, B. A., Gregory, A. K. & Fathman, C. G. (1988) Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T- helper lymphocytes. Science 240, 659. Smith, K. A. (1988) lnterleukin-2: Inception, impact and implications. Science 240, 1169. Sriman, S., Carroll, L., Fortin, S., Cooper, S. & Ranges, G. (1988) In vivo immunomodulation by monoclonal anti-CD4 antibody: effect on T cell response to myelin basic protein and experimental allergic encephalomyelitis, J. Immunol. 141, 464. Steinbrocker, O., Traeger, C. & Batterman, R. C. (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140, 659. Swaak, A. J., Van Rooyen, A., Nieuwenhuis, E. & Aarden, L. A. (1988) Interleukin 6 in synovial fluid and serum of patients with rheumatic diseases. Scand, J. Rheumatol. 17, 469. Tiberghien, P., Racadot, E., Lioure, B., Delain, M., Girard, A., Wijdenes, J., Plouvier, E., Flesch, M., Cahn, J. Y. & Herve, P. (1991) Soluble CD8, IL-2 receptor and serum tumor necrosis factor alpha levels in steroid-resistant acute graft-versus-host disease: relation with subsequent response to an anti IL-2 receptor monoclonal antibody treatment. Transplantation 52, 475. Traugott, U., Reinherz, E. L. & Raine, C. S. (1983) Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 219, 308. Trotter, J. L., Wegescheide, C. L. & Garvey, W F. (1983) Immunoreactive myelin proteolipid protein-like activity in cerebrospinal fluid and serum of neurologically impaired patients. Ann. Neurol. 14, 554. Van Eden, W. (1990) T ceil regulation in autoimmune arthritis: possibilities for immunological intervention. Immunol. Res. 9, 157. Van Lambalgen, R. & Jonker, M. (1987) Experimental allergic encephalomyelitis in rhesus monkeys, II, Treatment of EAE with anti-T lymphocyte subset monoclonal antibodies. Clin. Exp. Immunol. 67, 305. Veillette, A., Bookman, M. A., Horak, E. M., Samelson, L. E. & Bolen, J. B. (1989) Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p561ck. Nature 338, 257. Volk, H. D., Brocke, S., Osawa, H. & Diamantstein, T. (1986) Effects of in vivo administration of a monoclonal antibody specific for the IL-2 receptor on the acute GvHR in mice. Clin. Exp. Immunol. 66, 126. Waksman, B. H. & Reynolds, W E. (1984) Multiple sclerosis as a disease of immune regulation. Proc. Soc. Exp. Biol. Med 294, 175. Waldmann, H. (1988) Immunosuppression with monoclonal antibodies: some speculations about tolerance in the context of tissue grafting. Transplant. Proc. 20, 46. Waldmann, H. (1989) Manipulation of T-cell responses with monoclonal antibodies, Ann. Rev. Immunol. 7, 407. Weisdorf, D., Haake, E., Biazar, B., Miller, W. McGlave, P. Ramsay, N. Kersey, J. & Filipovitch, A. (1990) Treatment of moderate/severe acute GvHD after allogeneic BMT: an analysis of clinical risk features and outcome. Blood 15, 1024. Wendling, D., Wijdenes, J., Racadot, E. & Morel-Fourder, B. (1991) Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis. J. Rheumatol. 18, 325. Wijdenes, J., Clement, C. Klein, B., Morel-Fourder, B., Vita, N., Ferrara, P. & Peters, A. (1991) Human recombinant dimeric IL6 binds to its receptor as detected by anti IL6 monoclonal antibody. Molecular Immunol. 28, 1183. J. Wijdenes, C. Clement B. Morel-Fourrier, R. Beliard, R Herve & A. Peters (1989) A monoclonal antibody against the human IL-2 receptor with high inhibitory activity on IL-2 induced proliferation of T cells, experimental and clinical results. In: Progress in Leukocyte Biology Eds. J. G. Kaplan, D. R. Green & R. C. Bleackly Cellular Basis of Immune Modulation, vol 9. Liss, New York : 551. Wilde, D. B., Marrack, P. Kappler, J., Dialynas, D. & Fitch, F W. (1983) Evidence implicating L3T4 in class II MHC antigen reactivity: monoclonal antibody GK1, 5 (anti L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines and binding by cloned murine helper T lymphocyte lines. J. Immunol. 131, 2178. Wilder, R. L. (1990) Rheumatoid arthritis and related conditions. Immunology 2, 613. Wucherpfennig, K. W. Weiner, H. L. & Hafler, D. A. (1991) T-cell recognition of myelin basic protein. Immunol. Today 8, 579. Citing Literature Volume129, Issue1October 1992Pages 31-55 ReferencesRelatedInformation" @default.
• W2115022311 created "2016-06-24" @default.
• W2115022311 creator A5015380178 @default.
• W2115022311 creator A5022620505 @default.
• W2115022311 creator A5028612887 @default.
• W2115022311 creator A5029675225 @default.
• W2115022311 creator A5043616696 @default.
• W2115022311 creator A5048011356 @default.
• W2115022311 creator A5052222429 @default.
• W2115022311 creator A5057923069 @default.
• W2115022311 date "1992-10-01" @default.
• W2115022311 modified "2023-10-16" @default.
• W2115022311 title "Use of Monoclonal Antibodies in vivo as a Therapeutic Strategy for Alloimmune or Autoimmune Reactivity: The Besancon Experience" @default.
• W2115022311 cites W1500757144 @default.
• W2115022311 cites W1501734887 @default.
• W2115022311 cites W1502410816 @default.
• W2115022311 cites W1544569979 @default.
• W2115022311 cites W1546580007 @default.
• W2115022311 cites W1564801833 @default.
• W2115022311 cites W1583260832 @default.
• W2115022311 cites W1599864954 @default.
• W2115022311 cites W1855316965 @default.
• W2115022311 cites W1915916556 @default.
• W2115022311 cites W1978345766 @default.
• W2115022311 cites W1986075832 @default.
• W2115022311 cites W1987171508 @default.
• W2115022311 cites W1987930131 @default.
• W2115022311 cites W1993051112 @default.
• W2115022311 cites W1998455368 @default.
• W2115022311 cites W2010435662 @default.
• W2115022311 cites W2028180466 @default.
• W2115022311 cites W2031989842 @default.
• W2115022311 cites W2034669414 @default.
• W2115022311 cites W2036688360 @default.
• W2115022311 cites W2040347034 @default.
• W2115022311 cites W2040938880 @default.
• W2115022311 cites W2042818781 @default.
• W2115022311 cites W2044907066 @default.
• W2115022311 cites W2045590518 @default.
• W2115022311 cites W2065371697 @default.
• W2115022311 cites W2071989019 @default.
• W2115022311 cites W2082866606 @default.
• W2115022311 cites W2086986045 @default.
• W2115022311 cites W2088158803 @default.
• W2115022311 cites W2089037219 @default.
• W2115022311 cites W2089862878 @default.
• W2115022311 cites W2094292853 @default.
• W2115022311 cites W2098015378 @default.
• W2115022311 cites W2106546691 @default.
• W2115022311 cites W2109168421 @default.
• W2115022311 cites W2110778359 @default.
• W2115022311 cites W2112165124 @default.
• W2115022311 cites W2116594823 @default.
• W2115022311 cites W2120563866 @default.
• W2115022311 cites W2121726036 @default.
• W2115022311 cites W2126592963 @default.
• W2115022311 cites W2130355701 @default.
• W2115022311 cites W2133692536 @default.
• W2115022311 cites W2135208058 @default.
• W2115022311 cites W2143037496 @default.
• W2115022311 cites W2143053368 @default.
• W2115022311 cites W2150602579 @default.
• W2115022311 cites W2151195343 @default.
• W2115022311 cites W2152348310 @default.
• W2115022311 cites W2168990989 @default.
• W2115022311 cites W2172011800 @default.
• W2115022311 cites W2381731949 @default.
• W2115022311 cites W4238476387 @default.
• W2115022311 cites W4244481942 @default.
• W2115022311 doi "https://doi.org/10.1111/j.1600-065x.1992.tb01418.x" @default.
• W2115022311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1464420" @default.
• W2115022311 hasPublicationYear "1992" @default.
• W2115022311 type Work @default.
• W2115022311 sameAs 2115022311 @default.
• W2115022311 citedByCount "21" @default.
• W2115022311 crossrefType "journal-article" @default.
• W2115022311 hasAuthorship W2115022311A5015380178 @default.
• W2115022311 hasAuthorship W2115022311A5022620505 @default.
• W2115022311 hasAuthorship W2115022311A5028612887 @default.
• W2115022311 hasAuthorship W2115022311A5029675225 @default.
• W2115022311 hasAuthorship W2115022311A5043616696 @default.
• W2115022311 hasAuthorship W2115022311A5048011356 @default.
• W2115022311 hasAuthorship W2115022311A5052222429 @default.
• W2115022311 hasAuthorship W2115022311A5057923069 @default.
• W2115022311 hasConcept C142724271 @default.
• W2115022311 hasConcept C150903083 @default.
• W2115022311 hasConcept C159654299 @default.
• W2115022311 hasConcept C163864487 @default.
• W2115022311 hasConcept C203014093 @default.
• W2115022311 hasConcept C204787440 @default.
• W2115022311 hasConcept C207001950 @default.
• W2115022311 hasConcept C2776910235 @default.
• W2115022311 hasConcept C542903549 @default.
• W2115022311 hasConcept C71924100 @default.
• W2115022311 hasConcept C86803240 @default.
• W2115022311 hasConceptScore W2115022311C142724271 @default.
• W2115022311 hasConceptScore W2115022311C150903083 @default.
• W2115022311 hasConceptScore W2115022311C159654299 @default.

• next